Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George A Doss

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2003
A novel P450-catalyzed transformation of the 2,2,6,6-tetramethyl piperidine moiety to a 2,2-dimethyl pyrrolidine in human liver microsomes: characterization by high resolution quadrupole-time-of-flight mass spectrometry and 1H-NMRWenji Yin, George A Doss, Ralph A Stearns, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometryDavid Q Liu, Bindhu V Karanam, George A Doss, et al.
Organic Letters|January 28, 2005
Estrogen receptor ligands. 12. Synthesis of the major metabolites of an ERalpha-selective, dihydrobenzoxathiin antagonist for osteoporosisSeongkon Kim, Jane Y Wu, Zhoupeng Zhang, et al.
Organic Letters|May 25, 2002
Novel fragmentation reaction of correolideJianming Bao, Robert K Baker, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2004
Identification and metabolism of a novel dihydrohydroxy-S-glutathionyl conjugate of a peroxisome proliferator-activated receptor agonist, MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], in ratsVijay Bhasker G Reddy, George A Doss, Mellissa Creighton, et al.
Organic Letters|January 30, 2004
Citrafungins A and B, two new fungal metabolite inhibitors of GGTase I with antifungal activitySheo B Singh, Deborah L Zink, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
In vitro metabolic activation of lumiracoxib in rat and human liver preparationsYing Li, J Greg Slatter, Zhoupeng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2006
Highly constrained bicyclic VLA-4 antagonistsLinda L Chang, Quang Truong, George A Doss, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitorsWallace T Ashton, Hong Dong, Rosemary M Sisco, et al.
Pharmaceutical Research|December 17, 2008
Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transportersXiao-Yan Chu, Yuexia Liang, Xiaoxin Cai, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2003
A novel P450-catalyzed transformation of the 2,2,6,6-tetramethyl piperidine moiety to a 2,2-dimethyl pyrrolidine in human liver microsomes: characterization by high resolution quadrupole-time-of-flight mass spectrometry and 1H-NMRWenji Yin, George A Doss, Ralph A Stearns, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometryDavid Q Liu, Bindhu V Karanam, George A Doss, et al.
Organic Letters|January 28, 2005
Estrogen receptor ligands. 12. Synthesis of the major metabolites of an ERalpha-selective, dihydrobenzoxathiin antagonist for osteoporosisSeongkon Kim, Jane Y Wu, Zhoupeng Zhang, et al.
Organic Letters|May 25, 2002
Novel fragmentation reaction of correolideJianming Bao, Robert K Baker, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2004
Identification and metabolism of a novel dihydrohydroxy-S-glutathionyl conjugate of a peroxisome proliferator-activated receptor agonist, MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], in ratsVijay Bhasker G Reddy, George A Doss, Mellissa Creighton, et al.
Organic Letters|January 30, 2004
Citrafungins A and B, two new fungal metabolite inhibitors of GGTase I with antifungal activitySheo B Singh, Deborah L Zink, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
In vitro metabolic activation of lumiracoxib in rat and human liver preparationsYing Li, J Greg Slatter, Zhoupeng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2006
Highly constrained bicyclic VLA-4 antagonistsLinda L Chang, Quang Truong, George A Doss, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitorsWallace T Ashton, Hong Dong, Rosemary M Sisco, et al.
Pharmaceutical Research|December 17, 2008
Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transportersXiao-Yan Chu, Yuexia Liang, Xiaoxin Cai, et al.
Pageof 4